Allakos Inc (ALLK)

$0.92

+0.05

(+5.79%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $0.87
    $0.92
    $0.92
    downward going graph

    5.43%

    Downside

    Day's Volatility :5.43%

    Upside

    0.0%

    downward going graph
  • $0.68
    $5.64
    $0.92
    downward going graph

    26.63%

    Downside

    52 Weeks Volatility :88.03%

    Upside

    83.69%

    downward going graph

Returns

PeriodAllakos IncSector (Health Care)Index (Russel 2000)
3 Months
-15.2%
6.5%
0.0%
6 Months
-33.46%
7.1%
0.0%
1 Year
-81.75%
9.8%
0.0%
3 Years
-98.94%
14.2%
-20.2%

Highlights

Market Capitalization
77.9M
Book Value
$1.17
Earnings Per Share (EPS)
-2.46
Wall Street Target Price
2.8
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-46.6%
Return On Equity TTM
-111.56%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-191.0M
Diluted Eps TTM
-2.46
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.54
EPS Estimate Next Year
-0.72
EPS Estimate Current Quarter
-0.47
EPS Estimate Next Quarter
-0.32

Analyst Recommendation

Buy
    53%Buy
    40%Hold
    6%Sell
Based on 15 Wall street analysts offering stock ratings for Allakos Inc(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
6
6
6
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 204.35%

Current $0.92
Target $2.80

Technicals Summary

Sell

Neutral

Buy

Allakos Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Allakos Inc
Allakos Inc
-18.4%
-33.46%
-81.75%
-98.94%
-97.45%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Allakos Inc
Allakos Inc
NA
NA
NA
-1.54
-1.12
-0.47
NA
1.17
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Allakos Inc
Allakos Inc
Buy
$77.9M
-97.45%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Allakos Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 143.4%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 285.4%

Institutional Holdings

  • Bvf Inc

    18.69%

  • NEA Management Company, LLC

    6.94%

  • Deep Track Capital, LP

    5.65%

  • BlackRock Inc

    5.33%

  • Vanguard Group Inc

    4.29%

  • Redmile Group, LLC

    3.90%

Company Information

allakos inc is a biotechnology company located in 7400 paseo padre pkwy, fremont, ca, united states.

Organization
Allakos Inc
Employees
131
CEO
Dr. Robert Alexander Ph.D.
Industry
Health Technology

Discover More

FAQs